Skip to main content

VivoSim Labs, INC.

VIVS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001497253

In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding VivoSim Labs, INC. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of VIVS: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders34340
Shares884.9K2.33M+1.44M (+163.0%)
Value$911.7K$1.77M+$861.5K (+94.5%)

New holders (6)

Institutions that held VivoSim Labs, INC. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to VIVS in Q2 2024
InstitutionSharesValue% of portfolio
Armistice Capital, LLC929,000$708.0K0.02%
Prescott Group Capital Management, L.L.C.474,004$361.0K0.06%
Coppell Advisory Solutions LLC125$950.00%
McIlrath & Eck, LLC35$270.00%
Redwood Wealth Management Group, LLC25$190.00%
TD Waterhouse Canada Inc.10$80.00%

Sold out (6)

Institutions that held VivoSim Labs, INC. at the end of Q1 2024 and filed for Q2 2024 without it.